U.S. Pharma Stock News

Ryan Specialty Holdings (RYAN) is back in focus after reporting 2025 revenue of more than US$3.05b, completing five acquisitions, and launching its three year Empower Program to streamline operations and cut costs. See our latest analysis for Ryan Specialty Holdings. Despite the Empower Program and recent acquisitions getting attention, Ryan Specialty Holdings’ 1 day share price return of 1% and 7 day share price return of 0.9% sit against a 30 day share price decline of 16.4%, a year to date...

If you are wondering whether Bel Fuse shares still offer value after a strong run, this article explains what the current price might be implying about the business. The stock closed at US$172.94 recently, with a 7 day return of an 18.4% decline and a 30 day return of a 16.0% decline, while the 1 year return sits at 119.7% and the 3 year return is very large. These price moves sit against a backdrop of ongoing attention on Bel Fuse within the tech sector, as investors reassess companies that...

Bio-Techne recently presented at the TD Cowen 46th Annual Health Care Conference on March 3, 2026, at the Boston Marriott Copley Place Hotel in Boston, Massachusetts, sharing its latest updates with investors and industry participants. This conference appearance came shortly after broader healthcare sector concerns tied to a weak February jobs report, linking Bio-Techne’s story more closely to macroeconomic sentiment than to company-specific developments. We’ll now examine how sector-wide...

If you are wondering whether Millrose Properties at around US$29.77 is offering genuine value or just looks cheap on the surface, you are not alone. The stock has pulled back with a 4.0% decline over the past week and a 6.1% decline over the past month, yet it still sits on a 50.2% return over the last year and is close to flat year to date at a 0.2% decline. Recent news around Millrose has focused on its position as a listed real estate player, including ongoing coverage of its portfolio...

In February 2026, EOG Resources reported fourth-quarter and full-year 2025 results showing revenue of US$5,638 million for the quarter and US$22.63 billion for the year, alongside lower net income, and declared a US$1.02 per-share dividend payable on April 30, 2026. The company paired softer earnings with meaningfully higher oil and gas production volumes and detailed 2026 output guidance, giving investors a clearer view of its operating profile and capital returns priorities. Next, we will...

Earnings, production and dividend decisions in focus Coterra Energy (CTRA) has drawn fresh attention after fourth quarter and full year 2025 results, new 2026 production guidance and a quarterly dividend affirmation combined with supportive views from several research firms. See our latest analysis for Coterra Energy. Coterra’s shares trade at US$31.03, with a 90 day share price return of 16.79% and a 1 year total shareholder return of 23.11%. This suggests momentum has picked up recently...

Strategy (MSTR) is back in focus after Bitcoin touched a one month high. The company added 3,015 bitcoins, lifting its holdings above 720,000 BTC and benefiting from friendlier US crypto policy signals. See our latest analysis for Strategy. Despite the latest Bitcoin-driven bounce and friendlier policy signals, Strategy’s recent momentum has been weak, with a 90 day share price return showing a 29.35% decline and a 1 year total shareholder return of a 44.19% loss, contrasting with a very...

Baidu's AI chip unit Kunlunxin is preparing for an IPO expected to be completed by the first half of 2026. The planned listing could allow Kunlunxin to be included in Southbound Trading of Stock Connects after the IPO. The move highlights Baidu's focus on AI hardware alongside its core internet and AI services business. For investors following NasdaqGS:BIDU, Kunlunxin sits at the intersection of Baidu's AI research and the growing demand for specialized chips. The subsidiary focuses on AI...

Why VICI Properties Is On Investors’ Radar VICI Properties (VICI) has drawn fresh attention after recent share moves, with the stock showing mixed returns over the past year and a modest gain over the past 3 months. See our latest analysis for VICI Properties. At a share price of $29.67, VICI’s recent 30-day share price return of 3.16% and 90-day share price return of 6.88% sit against a 1-year total shareholder return of 3.78% decline. This suggests momentum has been picking up after a...

Shake Shack Inc. recently reported fourth-quarter 2025 revenue of US$400.53 million and net income of US$11.83 million, alongside full-year 2025 revenue of US$1.45 billion and net income of US$45.73 million, and its CEO is set to present at Loop's 7th Annual Investor Conference 2026 in New York. The combination of strong year-on-year improvements in earnings per share and upcoming investor conference commentary offers investors fresh insight into how Shake Shack is managing growth, costs,...

Sable Offshore Corp. recently reported its full-year 2025 results, recording a net loss of US$410.16 million, while its auditor issued an unqualified opinion that raised doubt about the company’s ability to continue as a going concern. At the same time, a Department of Justice Office of Legal Counsel opinion indicated that a presidential order under the Defense Production Act could override California laws restricting Sable Offshore’s key California pipeline and offshore operations,...

In recent weeks, Commvault Systems has expanded its cyber resilience portfolio by adding Okta support, deepening integrations with CrowdStrike and CloudSEK, and partnering with European sovereign cloud provider STACKIT to enhance secure, immutable data protection and identity recovery capabilities. By tying together identity recovery, dark web credential intelligence, SIEM visibility, and EU-sovereign cloud storage, Commvault is positioning its platform more squarely at the intersection of...

BioMarin Pharmaceutical (BMRN) is back in focus after the FDA approved a supplemental Biologics License Application for PALYNZIQ, expanding treatment eligibility to pediatric phenylketonuria patients aged 12 and older. See our latest analysis for BioMarin Pharmaceutical. The PALYNZIQ approval lands after a stretch where BioMarin’s share price has shown improving momentum, with a 13.73% 90 day share price return and a 5.14% 30 day share price return, even though the 1 year total shareholder...

In late February 2026, McGrath RentCorp reported fourth-quarter and full-year 2025 results, issued full-year 2026 revenue guidance of US$945 million to US$995 million, and declared a quarterly cash dividend of US$0.495 per share payable on April 30, 2026. While full-year net income declined compared with 2024, the combination of higher quarterly earnings, continued revenue growth and a 2% dividend increase highlighted management’s confidence in the business and its cash-generation...

Baker Hughes has priced $6.5b in US dollar senior notes and €3b in euro senior notes to fund its proposed acquisition of Chart Industries. The financing packages are backed by major international banks and are intended to support a large cross border transaction. The move follows recent client wins, including power solutions for advanced data centers and experimental reactors. NasdaqGS:BKR is trading at $59.81, with the share price up 26.9% year to date and 42.3% over the past year. Over a...

Hilton Grand Vacations (HGV) just paired a completed share buyback with fresh earnings, giving investors two key updates on capital returns and profitability to weigh when thinking about the stock today. See our latest analysis for Hilton Grand Vacations. At a share price of $43.54, Hilton Grand Vacations has had a mixed run, with a recent 1-day share price return of a 3.82% decline and a 30-day share price return of an 8.61% decline, even as the 1-year total shareholder return of 16.01%...

If you are wondering whether Microsoft is still fairly priced after its long run as a market heavyweight, looking closely at its current valuation can help you decide how it might fit into your portfolio. The stock last closed at US$408.96, with returns of 2.6% over the past 7 days, 1.9% over the past 30 days, a year-to-date return of a 13.5% decline, and 8.4% over the past year. The 3-year and 5-year returns sit at 64.9% and 81.5% respectively. Recent headlines around Microsoft have focused...

In early March 2026, Kennametal faced pressure after a weaker-than-expected U.S. February jobs report showed the manufacturing sector losing 12,000 positions, raising concerns about softer industrial activity. This macro shock matters because Kennametal’s tools and materials are closely tied to manufacturing demand, making labor-market softness a key watchpoint for its outlook. Against this backdrop of softer manufacturing employment, we’ll now examine how the latest data may influence...

In recent weeks, Badger Meter has faced cautious analyst sentiment ahead of an upcoming earnings release that is expected to show year-over-year EPS decline despite higher revenue, alongside insider share sales by senior executives Fred Begale and Kimberly Stoll over the past year. This combination of softer earnings expectations, premium valuation concerns, and ongoing insider selling has sharpened investor focus on how durable Badger Meter’s growth and profitability thesis really is. Now...

Lumentum Holdings (NasdaqGS:LITE) has entered a multiyear alliance with NVIDIA focused on optical technology for next generation AI infrastructure. The agreement includes a $2b investment tied to R&D collaboration, manufacturing capacity, and a large purchase commitment. The partnership is aimed at accelerating optical solutions that support AI data centers and related infrastructure. Lumentum Holdings, trading at $558.44, has seen a very large 1 year return and a more than 10x move over 3...

Why Kinder Morgan is back in focus Kinder Morgan (KMI) is back on investor radar after reporting strong quarterly results, expanding its natural gas project backlog to US$10b, and benefiting from higher oil prices driven by rising U.S.-Iran tensions. See our latest analysis for Kinder Morgan. The renewed interest has been reflected in Kinder Morgan’s share price, which has a 30 day share price return of 10.1% and a 90 day share price return of 23.05%. Its 1 year total shareholder return of...

On February 24, 2026, Brady Corporation’s board declared a US$0.245 per-share dividend on Class A common stock, payable April 30, 2026, to shareholders of record as of April 9, 2026. This dividend decision comes alongside multi-year growth in sales, earnings, and free cash flow, underscoring Brady’s capacity to return cash to investors. We’ll now examine how Brady’s dividend declaration, against a backdrop of solid multi-year earnings and cash flow growth, influences its investment...

Recent performance snapshot Stifel Financial (SF) has been under pressure recently, with the share price showing a 2.6% decline over the past day, a 16.0% decline over the past month, and a 12.7% decline over the past 3 months. See our latest analysis for Stifel Financial. Zooming out, Stifel Financial’s recent share price weakness, including the 16.0% 30 day share price decline, contrasts with a 1 year total shareholder return of 15.8% and a 3 year total shareholder return close to 2x. This...

PBF Energy (PBF) has drawn investor attention after its shares closed at US$43.25. Recent returns over the month and past 3 months contrast with a 1 day pullback. See our latest analysis for PBF Energy. The 1 day share price pullback sits against a much stronger backdrop, with a 30 day share price return of 21.8% and a year to date share price return of 51.6%. The 1 year total shareholder return of 112% points to momentum that has been building rather than fading. If PBF Energy’s move has you...